Sort
85,873 grants matching “alzheimers”
Plasma tau and neurodegenerative markers as predictors of rate of AD progression
$848,183Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2024 · AG
A Novel Waveguide to Enable MAS-DNP-NMR in Standard-bore High-field Magnets
$848,143Francis David Doty · Doty Scientific, Inc. · R44 · FY2024 · GM
Mechanisms of Alzheimer's Disease Progression in the Aging Brain
$848,137William J. Jagust · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2019 · AG
Computerized tests of cognitive decline in presymptomatic Alzheimer's disease
$848,084David L Woods · Neurobehavioral Systems, Inc. · R44 · FY2021 · AG
Novel automated performance-based ADL outcomes for early AD clinical trials
$848,052Gad Asher Marshall · Brigham And Women'S Hospital · R01 · FY2019 · AG
Making Connections Thru Music: A Group Music Therapy-Based Intervention for Persons with Dementia
$847,861Gregg Gorzelle · Hopeful Aging Llc · R42 · FY2024 · AG
New tools for understanding the blood brain barrier
$847,500Chenghua Gu · Harvard Medical School · DP1 · FY2017 · NS
New tools for understanding the blood brain barrier
$847,500Chenghua Gu · Harvard Medical School · DP1 · FY2014 · NS
New tools for understanding the blood brain barrier
$847,500Chenghua Gu · Harvard Medical School · DP1 · FY2015 · NS
New tools for understanding the blood brain barrier
$847,500Chenghua Gu · Harvard Medical School · DP1 · FY2016 · NS
cGAS inhibitors for Alzheimer's disease treatment
$847,498Subhash C Sinha · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG
cGAS inhibitors for Alzheimer's disease treatment
$847,498Li Gan · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AG
cGAS inhibitors for Alzheimer's disease treatment
$847,498Li Gan · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
cGAS inhibitors for Alzheimer's disease treatment
$847,498Subhash C Sinha · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$847,487Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
$847,416Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2023 · AG
Leveraging the national infrastructure of trusted organizations to increase representation of Latinos in dementia research
$847,349Elena Portacolone · University Of California, San Francisco · R24 · FY2021 · AG
Administrative Core
$847,321Thomas J Montine · University Of Washington · P50 · FY2015 · AG
Multicenter Study on Exceptional Survival in Families
$847,227Richard Mayeux · Columbia University Health Sciences · U01 · FY2007 · AG
In VivoPIB PET Amyloid Imaging: Normals, MCI &Dementia
$847,226University Of Pittsburgh At Pittsburgh · P01 · FY2005 · AG
Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease
$847,144Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2021 · AG
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease
$847,141Yu-Shin Ding · New York University School Of Medicine · R01 · FY2021 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
$847,139Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG
P75 Small Molecule Ligands for Alzheimer's Therapy
$847,101Frank M Longo · Stanford University · U01 · FY2008 · AG
NIA COMMUNICATION ACTIVITIES TO SUPPORT THE IMPLEMENTATION OF THE NATIONAL STRATEGY FOR RECRUITMENT AND PARTICIPATION IN ALZHEIMER'S AND RELATED DEMEN
$847,022Andrew Hale · Fors Marsh Group Llc · N02 · FY2020 · DA